The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Plasma Cell Leukemia: Diagnostic and Treatment Approach

Aggressive plasma cell malignancy with circulating clonal cells

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Plasma Cell Leukemia: Diagnostic and Treatment Approach?

Plasma cell leukemia (PCL) is defined by circulating clonal plasma cells comprising 5 percent or more of peripheral blood leukocytes (revised 2021 criteria).

Primary PCL presents de novo without prior multiple myeloma diagnosis and accounts for about 60 percent of cases.

Secondary PCL evolves from previously diagnosed multiple myeloma and signals a leukemic transformation.

Carries adverse cytogenetic features more frequently: del17p, t(14;16), 1q gain, and complex karyotype.

Median survival historically poor (under 12 months) but improving with quadruplet induction and early transplantation.

Symptoms

Severe fatigue and weakness from anemia and high tumor burden.
Bone pain and pathological fractures from osteolytic lesions.
Hypercalcemia with confusion, polyuria, and constipation.
Renal dysfunction from light chain cast nephropathy or hypercalcemic injury.
Hepatosplenomegaly and lymphadenopathy more common than in classic myeloma.

Risk Factors

Advanced age and frailty limit transplant eligibility.
High-risk cytogenetics worsen prognosis significantly.
Extramedullary disease at presentation indicates aggressive biology.
Renal failure at diagnosis adds treatment complexity.
Prior multiple myeloma with secondary transformation has worse outcomes.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • New onset bone pain unresponsive to analgesics.
  • Confusion, severe thirst, or polyuria suggesting hypercalcemia.
  • Worsening fatigue, pallor, or unusual bleeding.
  • Recurrent or severe infections during initial workup.
  • Significant kidney function changes or new edema.

Treatment Methods

01
Quadruplet induction: daratumumab plus bortezomib, lenalidomide, and dexamethasone (Dara-VRd) when feasible.
02
Alternative regimens: VDT-PACE, KRd (carfilzomib-lenalidomide-dexamethasone), or VTD.
03
Early autologous stem cell transplant in transplant-eligible patients with adequate response.
04
Tandem auto-allo transplantation considered in young, fit patients with high-risk features.
05
CAR-T therapy and bispecific antibodies under investigation for relapsed/refractory PCL.

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.